SUBSCRIBE
SUBSCRIBE
News   Job Trends

Abbott Laboratories to Cut 3,000 Jobs Following Solvay Pharmaceuticals, Inc. Deal

September 21, 2010 | 
1 min read

NEW YORK, Sept 21 (Reuters) - Abbott Laboratories Inc (ABT.N) plans to cut 3,000 jobs, or about 3 percent of its workforce, following its purchase of Solvay’s (SOLB.BR) pharmaceuticals business.

Job creations People
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Cellectar Downsizes by 60% as it Explores Strategic Options for Cancer Drug
December 11, 2024
 · 
202 min read
 · 
BioSpace Editorial Staff
Group Of Employees Being Fired By Their Company.
Layoffs
Carisma Therapeutics to Cut 34% of Staff, Reprioritize Pipeline
December 10, 2024
 · 
2 min read
 · 
Angela Gabriel
Amgen sign at its headquarters in Thousand Oaks, California, USA.
Manufacturing
Amgen to Add 370 New Jobs in North Carolina With $1B Manufacturing Investment
December 6, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: Office building science collage
Career Advice
The Top 12 Companies Hiring in Biopharma Now
December 5, 2024
 · 
1 min read
 · 
Angela Gabriel